Published in J Neurochem on November 01, 1997
A unified framework for addiction: vulnerabilities in the decision process. Behav Brain Sci (2008) 2.83
Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci (2011) 1.83
Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol (2009) 1.76
Review. Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci (2008) 1.62
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry (2009) 1.53
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berl) (2005) 1.14
Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochem Pharmacol (2009) 1.09
Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A (2001) 1.09
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy. Pharmacol Ther (2009) 1.04
Prenatal nicotine exposure and development of nicotinic and fast amino acid-mediated neurotransmission in the control of breathing. Respir Physiol Neurobiol (2008) 1.00
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Hum Genet (2012) 0.92
Neurophysiology of Nicotine Addiction. J Addict Res Ther (2011) 0.91
Impact of chronic nicotine on the development and maintenance of neuropathic hypersensitivity in the rat. Psychopharmacology (Berl) (2006) 0.84
Involvement of cholinergic mechanisms in the behavioral effects of dietary fat consumption. Brain Res (2012) 0.83
Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population. J Neural Transm (Vienna) (2008) 0.82
Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures. J Pharmacol Exp Ther (2012) 0.81
Effect of nicotine on cerebellar granule neuron development. Eur J Neurosci (2001) 0.80
Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences. J Pediatr Biochem (2010) 0.80
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain. J Neurochem (2014) 0.80
Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet. Psychopharmacology (Berl) (2013) 0.79
Chronic nicotine alters nicotinic receptor-induced presynaptic Ca2+ responses in isolated nerve terminals. Neurochem Res (2007) 0.78
Impact of chronic nicotine on sciatic nerve injury in the rat. J Neuroimmunol (2007) 0.78
Increased spinal dynorphin contributes to chronic nicotine-induced mechanical hypersensitivity in the rat. Neurosci Lett (2007) 0.77
Re-evaluation of nicotinic acetylcholine receptors in rat brain by a tissue-segment binding assay. Front Pharmacol (2011) 0.77
Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors. J Biol Chem (2011) 0.77
Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates. Psychopharmacology (Berl) (2016) 0.76
AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors. Mol Pharmacol (2015) 0.75
Upregulation of Nicotinic Acetylcholine Receptor alph4+beta2 through a Ligand-Independent PI3Kbeta Mechanism That Is Enhanced by TNFalpha and the Jak2/p38Mapk Pathways. PLoS One (2015) 0.75
Crucial roles of the CHRNB3-CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research. Transl Psychiatry (2016) 0.75
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol (1992) 3.20
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev (1999) 2.76
Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science (1983) 1.78
Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther (1999) 1.73
Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol Pharmacol (1998) 1.52
In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem (1985) 1.46
Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol (1995) 1.28
Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res (1986) 1.26
Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function. J Pharmacol Exp Ther (1989) 1.10
[3H]cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol (1991) 1.09
Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain. Mol Pharmacol (1982) 1.06
Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol (1981) 1.04
Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain. Nature (1979) 1.02
Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science (1981) 1.02
Lithium: effects on serotonin receptors in rat brain. Eur J Pharmacol (1980) 1.01
[3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J Pharmacol Exp Ther (1995) 1.00
Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors. Neuropharmacology (1985) 1.00
Agonist regulation of rat alpha 3 beta 4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells. Mol Pharmacol (2001) 1.00
Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology (Berl) (1987) 0.99
Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors. J Pharmacol Exp Ther (2000) 0.97
Neuronal nicotinic acetylcholine receptor alpha3 subunit protein in rat brain and sympathetic ganglion measured using a subunit-specific antibody: regional and ontogenic expression. J Neurochem (2001) 0.97
Acute effects of nicotine on prolactin release in the rat: agonist and antagonist effects of a single injection of nicotine. J Pharmacol Exp Ther (1990) 0.95
Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain. J Neurochem (1984) 0.95
[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther (1997) 0.95
Brainstem nicotinic receptor subtypes that influence intragastric and arterial blood pressures. J Pharmacol Exp Ther (2000) 0.95
Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology (1988) 0.93
Immobilized nicotinic receptor stationary phase for on-line liquid chromatographic determination of drug-receptor affinities. Anal Biochem (1998) 0.92
Experimental studies on the neurocardiovascular effects of urapidil. Drugs (1988) 0.92
Autonomic nervous system actions of cardiac glycosides. Biochem Pharmacol (1978) 0.90
Activation and Ca2+ permeation of stably transfected alpha3/beta4 neuronal nicotinic acetylcholine receptor. Mol Pharmacol (1999) 0.89
Stimulation of serotonin2 receptors in the ventrolateral medulla of the cat results in nonuniform increases in sympathetic outflow. Circ Res (1990) 0.88
Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine. J Pharmacol Exp Ther (1990) 0.87
Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. J Pharmacol Exp Ther (1979) 0.87
[3H]Tryptamine: high affinity binding sites in rat brain. Eur J Pharmacol (1982) 0.86
Evidence of a functional alpha7-neuronal nicotinic receptor subtype located on motoneurons of the dorsal motor nucleus of the vagus. J Pharmacol Exp Ther (2001) 0.86
Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch Neurol (1988) 0.86
Nicotinic receptor binding sites in rat primary neuronal cells in culture: characterization and their regulation by chronic nicotine. Brain Res Mol Brain Res (1999) 0.84
Electroconvulsive shock but not antidepressant drugs increases alpha 1-adrenoceptor binding sites in rat brain. Eur J Pharmacol (1987) 0.84
Nicotinic receptor mediates spontaneous GABA release in the rat dorsal motor nucleus of the vagus. Neuroscience (1997) 0.84
Gestational nicotine exposure regulates expression of AMPA and NMDA receptors and their signaling apparatus in developing and adult rat hippocampus. Neuroscience (2011) 0.83
Electroconvulsive shock and reserpine: effects on beta-adrenergic receptors in rat brain. J Neurochem (1981) 0.83
Liquid chromatographic studies with immobilized neuronal nicotinic acetylcholine receptor stationary phases: effects of receptor subtypes, pH and ionic strength on drug-receptor interactions. J Chromatogr B Biomed Sci Appl (1999) 0.83
[125/123I] 5-Iodo-3-pyridyl ethers. syntheses and binding to neuronal nicotinic acetylcholine receptors. Nucl Med Biol (2001) 0.82
[3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain. Mol Pharmacol (1987) 0.82
Quantitative autoradiography of nicotinic [3H]acetylcholine binding sites in rat brain. Neurosci Lett (1984) 0.82
Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. J Neurosci (1990) 0.82
Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals. Am J Med (1984) 0.81
Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil. J Pharmacol Exp Ther (1989) 0.81
Axotomy and nerve growth factor regulate levels of neuronal nicotinic acetylcholine receptor alpha3 subunit protein in the rat superior cervical ganglion. J Neurochem (2001) 0.81
[3H]tryptamine binding sites are not identical to monoamine oxidase in rat brain. J Neurochem (1988) 0.80
In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci (1986) 0.80
Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders. J Neural Transm Suppl (1987) 0.80
Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs. J Pharmacol Exp Ther (2001) 0.80
Ventrolateral medulla: an important site of action for the hypotensive effect of drugs that activate serotonin-1A receptors. J Cardiovasc Pharmacol (1990) 0.80
Pharmacology of neuronal nicotinic acetylcholine recceptors: effects of acute and chronic nicotine. Nicotine Tob Res (1999) 0.79
High-affinity binding of [3H]acetylcholine to muscarinic cholinergic receptors. J Neurosci (1985) 0.79
Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study. Brain Res (1989) 0.79
Origins of serotonin innervation of forebrain structures. Exp Neurol (1977) 0.79
Chronic reserpine administration selectively up-regulates beta 1- and alpha 1b-adrenergic receptors in rat brain: an autoradiographic study. Neuroscience (1992) 0.78
Regulation of brain nicotinic cholinergic recognition sites and prolactin release by nicotine. Prog Brain Res (1989) 0.78
Serotonin involvement in pituitary-adrenal function. Ann N Y Acad Sci (1977) 0.78
Electroconvulsive shock increases alpha 1b- but not alpha 1a-adrenoceptor binding sites in rat cerebral cortex. J Neurochem (1991) 0.77
[3H]acetylcholine binding sites in brain. Effect of disulfide bond modification. Mol Pharmacol (1983) 0.77
Effects of electroconvulsive shock and serotonin axon lesions on beta-adrenergic and serotonin-2 receptors in rat brain. Ann N Y Acad Sci (1986) 0.77
The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil. J Pharmacol Exp Ther (1991) 0.77
Effects of electroconvulsive shock on noradrenergic and serotonergic receptors in rat brain. Pharmacopsychiatry (1987) 0.77
Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res (1990) 0.77
Characterization of [3H]tryptamine binding sites in brain. Eur J Pharmacol (1983) 0.77
Electroconvulsive shock and reserpine increase alpha 1-adrenoceptor binding sites but not norepinephrine-stimulated phosphoinositide hydrolysis in rat brain. Eur J Pharmacol (1988) 0.77
Electroconvulsive shock decreases beta-adrenoceptors despite serotonin lesions. Eur J Pharmacol (1988) 0.76
Electroconvulsive shock differentially increases binding to alpha-1 adrenergic receptor subtypes in discrete regions of rat brain. J Neurosci (1990) 0.76
Electroconvulsive shock: effects on biochemical correlates of neurotransmitter receptors in rat brain. Neuropharmacology (1983) 0.76
Effects of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain. Eur J Pharmacol (1986) 0.76
In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine. Eur J Pharmacol (1995) 0.76
Role of alpha-2 adrenergic affinity in the action of a non-sedative antispasticity agent. Acta Neurol Scand (1982) 0.76
Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin. Neuroendocrinology (1992) 0.76
Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors. J Pharmacol Exp Ther (1994) 0.75
Alterations in brain monoamines and GABAA receptors in transgenic mice overexpressing TGF alpha. Pharmacol Biochem Behav (1995) 0.75
S-adenosyl-L-methionine modulates firing rate of dorsal motor nucleus of the vagus neurones in vitro. Eur J Pharmacol (1994) 0.75
Effect of diabetes on gold thioglucose lesions in rats. Proc West Pharmacol Soc (1975) 0.75
Regulation of beta adrenergic and serotonin-S2 receptors in brain by electroconvulsive shock and serotonin. Psychopharmacol Ser (1987) 0.75
A strong influence of serotonin axons on beta-adrenergic receptors in rat brain. Science (1985) 0.75
Inhibition of brain choline acetyltransferase in vivo: (E)-1-methyl-4-(1-naphthylvinyl)-1,2,3,6-tetrahydropyridine hydrochloride (B115), a depot form of a potent inhibitor. Toxicol Appl Pharmacol (1991) 0.75
Ventral medial hypothalamus: involvement in hypoglycemic convulsions. Science (1975) 0.75
Effect of in vivo deslanoside on the uptake of serotonin into platelets. Arch Int Pharmacodyn Ther (1979) 0.75
Naltrexone blocks nicotine-induced prolactin release. Neuropharmacology (1989) 0.75
Regulation of serotonin neurotransmission by antidepressant drugs and electroconvulsive shock: the fall and rise of serotonin receptors. Acta Pharmacol Toxicol (Copenh) (1985) 0.75
Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain. Mol Pharmacol (1989) 0.75
Effect of arrhythmogenic doses of deslanoside on the uptake of monoamines in brain tissue and in cardiac tissue. Eur J Pharmacol (1978) 0.75
Effect of deslanoside on brain and spinal cord levels of serotonin and 5-hydroxy-indoleacetic acid and tryptophan hydroxylase activity. Biochem Pharmacol (1978) 0.75
Effects of chronic phencyclidine on fixed-ratio responding: no relation to neurotransmitter receptor binding in rat cerebral cortex. Pharmacol Biochem Behav (1982) 0.75
Lithium effects on adrenergic receptor supersensitivity in rat brain. Eur J Pharmacol (1979) 0.75
Tetrahydro-beta-carbolines: affinities for tryptamine and serotonergic binding sites. Neuropharmacology (1982) 0.75
Tryptamine binding sites: potential site of action of tetrahydro-beta-carbolines. Prog Clin Biol Res (1982) 0.75